[Cerebral ictus and dihydroergotoxin methanesulfonate: a year of therapeutic trial].
D000368:Aged; D001488:Basilar Artery / Q000503:physiopathology; D002341:Carotid Artery Thrombosis / Q000188:drug therapy / Q000503:physiopathology; D002560:Cerebrovascular Circulation; D004341:Drug Evaluation; D004877:Ergoloid Mesylates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D014711:Vertebral Artery / Q000503:physiopathology
D004877:Ergoloid Mesylates
Ictus cérébral et méthanesulfonate de dihydroergotoxine. Une année d'essai thérapeutique